Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Diabetes - GeneralType 2 DiabetesGlycemic Control
Do you want to read an article? Please log in or register.